Journal article
Authors list: Lange, Uwe; Mueller-Ladner, Ulf; Dischereit, Gabriel
Publication year: 2017
Pages: 205-210
Journal: Journal of Physical and Rehabilitation Medicine
Volume number: 27
Issue number: 4
ISSN: 0940-6689
eISSN: 1439-085X
Open access status: Bronze
DOI Link: https://doi.org/10.1055/s-0043-113045
Publisher: Georg Thieme Verlag
Abstract:
A multimodal treatment of rheumatic diseases without physical medicine is incomplete. However, the mechanisms underlying the beneficial effects of physical medicine are only partially understood. Modern molecular medicine offers new insights into pivotal mechanisms and mediators of the inflammatory process and into interactions between cells of the immune system and bone cells. Investigating the potential influences of different methods of physical medicine on the central regulatory processes of inflammatory rheumatic diseases is of great interest, highly fascinating and opens up new avenues of research for the future. This article focuses on the novel results of molecular physical medicine in rheumatic diseases and osteoporosis.
Citation Styles
Harvard Citation style: Lange, U., Mueller-Ladner, U. and Dischereit, G. (2017) Rheumatic Diseases and Molecular Physical Medicine - New Aspects, Journal of Physical and Rehabilitation Medicine, 27(4), pp. 205-210. https://doi.org/10.1055/s-0043-113045
APA Citation style: Lange, U., Mueller-Ladner, U., & Dischereit, G. (2017). Rheumatic Diseases and Molecular Physical Medicine - New Aspects. Journal of Physical and Rehabilitation Medicine. 27(4), 205-210. https://doi.org/10.1055/s-0043-113045
Keywords
ANKYLOSING-SPONDYLITIS; BONE METABOLISM; INTERNATIONAL CLASSIFICATION; LOW-DOSE RADON; molecular physical medicine; musculoskeletal diseases; Physical medicine; PIVOTAL CYTOKINES; PSORIATIC-ARTHRITIS; THERAPEUTIC ADIT; WHOLE-BODY HYPERTHERMIA
